190 related articles for article (PubMed ID: 20620029)
21. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.
MacDonald K; Wilson M; Minassian A; Vilke GM; Becker O; Tallian K; Cobb P; Perez R; Galangue B; Feifel D
J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013
[TBL] [Abstract][Full Text] [Related]
22. Intramuscular olanzapine in patients with schizophrenia: an observational study in an emergency room.
Damsa C; Adam E; Lazignac C; De Gregorio F; Mihai A; Lejeune J; Sarasin F; Allen MH
Bull Soc Sci Med Grand Duche Luxemb; 2008; (2):209-16. PubMed ID: 18561597
[TBL] [Abstract][Full Text] [Related]
23. Intramuscular aripiprazole in the acute management of psychomotor agitation.
De Filippis S; Cuomo I; Lionetto L; Janiri D; Simmaco M; Caloro M; De Persis S; Piazzi G; Simonetti A; Telesforo CL; Sciarretta A; Caccia F; Gentile G; Kotzalidis GD; Girardi P
Pharmacotherapy; 2013 Jun; 33(6):603-14. PubMed ID: 23505124
[TBL] [Abstract][Full Text] [Related]
24. The utility of intramuscular ziprasidone in the management of acute psychotic agitation.
Mendelowitz AJ
Ann Clin Psychiatry; 2004; 16(3):145-54. PubMed ID: 15517847
[TBL] [Abstract][Full Text] [Related]
25. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
Daniel DG; Potkin SG; Reeves KR; Swift RH; Harrigan EP
Psychopharmacology (Berl); 2001 May; 155(2):128-34. PubMed ID: 11401000
[TBL] [Abstract][Full Text] [Related]
26. Intramuscular aripiprazole in the control of agitation.
Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
Miller DS; Yatham LN; Lam RW
J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM).
Gonzalez-Pinto A; Vieta E; Reed C; Novick D; Barraco A; Aguado J; Haro JM
J Affect Disord; 2011 Jun; 131(1-3):320-9. PubMed ID: 21195486
[TBL] [Abstract][Full Text] [Related]
29. Calming versus sedative effects of intramuscular olanzapine in agitated patients.
Battaglia J; Lindborg SR; Alaka K; Meehan K; Wright P
Am J Emerg Med; 2003 May; 21(3):192-8. PubMed ID: 12811711
[TBL] [Abstract][Full Text] [Related]
30. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
[TBL] [Abstract][Full Text] [Related]
31. Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder.
Lambert M; Huber CG; Naber D; Schacht A; Wagner TT; Hundemer HP; Karow A; Schimmelmann BG
Pharmacopsychiatry; 2008 Sep; 41(5):182-9. PubMed ID: 18763220
[TBL] [Abstract][Full Text] [Related]
32. Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study.
Alvarez E; Bobes J; Gómez JC; Sacristán JA; Cañas F; Carrasco JL; Gascón J; Gibert J; Gutiérrez M;
Eur Neuropsychopharmacol; 2003 Jan; 13(1):39-48. PubMed ID: 12480121
[TBL] [Abstract][Full Text] [Related]
33. Treatment of agitation in the acute psychiatric setting. An observational study of the effectiveness of intramuscular psychotropic medication.
Bauer JØ; Stenborg D; Lodahl T; Mønsted MM
Nord J Psychiatry; 2016 Nov; 70(8):599-605. PubMed ID: 27284637
[TBL] [Abstract][Full Text] [Related]
34. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.
Wright P; Lindborg SR; Birkett M; Meehan K; Jones B; Alaka K; Ferchland-Howe I; Pickard A; Taylor CC; Roth J; Battaglia J; Bitter I; Chouinard G; Morris PL; Breier A
Can J Psychiatry; 2003 Dec; 48(11):716-21. PubMed ID: 14733451
[TBL] [Abstract][Full Text] [Related]
35. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
Brook S
J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
[TBL] [Abstract][Full Text] [Related]
36. The comparative efficacy of intramuscular antipsychotics for the management of acute agitation.
Bosanac P; Hollander Y; Castle D
Australas Psychiatry; 2013 Dec; 21(6):554-62. PubMed ID: 23996795
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.
Tran-Johnson TK; Sack DA; Marcus RN; Auby P; McQuade RD; Oren DA
J Clin Psychiatry; 2007 Jan; 68(1):111-9. PubMed ID: 17284138
[TBL] [Abstract][Full Text] [Related]
39. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
Andrezina R; Josiassen RC; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; Iwamoto T
Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
